Inhaled nebulised unfractionated heparin improves lung function in moderate to very severe COPD: a pilot study

Medicine and Dentistry

• Heparin 100%
• Therapeutic Procedure 63%
• Anticoagulation 36%
• Placebo 36%
• Sputum 27%
• Exercise 27%
• Dyspnea 27%
• Lung 27%
• Patient 27%
• Follow up 18%
• Mucus 18%
• Adverse Event 18%
• Pulmonary Rehabilitation 18%
• Basic Protein 18%
• Inpatient 18%
• Coughing 18%
• Diseases 9%
• Morbidity 9%
• Pneumonia 9%
• Respiratory Disease 9%
• Serositis 9%
• Inhalation 9%
• Respiratory Tract Inflammation 9%
• Lactoferrin 9%
• Beclometasone Dipropionate 9%
• Polyarginine 9%
• Hyperinflation 9%
• Eosinophil Cationic Protein 9%
• Bronchoconstriction 9%
• Coagulation 9%
• Thrombocyte Factor 4 9%
• Lung Injury 9%
• Corticosteroid 9%
• Airflow 9%
• Salbutamol 9%
• Air Trapping 9%
• Combination Therapy 9%
• Mortality 9%
• Health 9%
• Hospital 9%
• Quality of Life 9%
• Assay 9%
• Aptitude 9%

INIS

• heparin 100%
• patients 45%
• lungs 45%
• exercise 27%
• proteins 27%
• inflammation 27%
• bids 27%
• anticoagulants 27%
• production 18%
• risks 18%
• capacity 18%
• diseases 18%
• doses 18%
• comparative evaluations 9%
• therapy 9%
• air 9%
• injuries 9%
• symptoms 9%
• quality of life 9%
• hospitals 9%
• morbidity 9%
• mortality 9%
• air flow 9%
• medicines 9%
• pneumonia 9%
• trapping 9%
• corticosteroids 9%
• inhalation 9%
• eosinophils 9%
• lactoferrin 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Heparin 100%
• Dyspnea 27%
• Adverse Event 18%
• Basic Protein 18%
• Coughing 18%
• Preclinical Study 18%
• Diseases 9%
• Inflammation 9%
• Morbidity 9%
• Respiratory Tract Disease 9%
• Lung Injury 9%
• Pneumonia 9%
• Salbutamol 9%
• Corticosteroid 9%
• Respiratory Tract Inflammation 9%
• Symptom 9%
• Mortality 9%
• Eosinophil Cationic Protein 9%
• Beclometasone Dipropionate 9%
• Thrombocyte Factor 4 9%
• Polyarginine 9%
• Bronchoconstriction 9%
• Lactoferrin 9%